Inflammatory Bowel Disease
Inflammatory Bowel Disease is a research topic within Genetics. Science Explorer counts 39k research works in it since 1950. 21.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the genetics, epidemiology, pathogenesis, and treatment of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. It covers topics such as host-microbe interactions, genetic susceptibility loci, immune system involvement, therapeutic targets, and the global burden of these diseases.
- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis
- Genetics
- Immunology
- Therapies
- Epidemiology
- Pathogenesis
- Biological Therapies
- Mucosal Healing
- Research works
- 39k fractional, since 1950
- In the world top 10%
- 8.5k per year above
- Top-10% rate
- 21.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +49% the tick is no change
Which countries lead Inflammatory Bowel Disease research?
By volume, the United States and China publish the most (1.9k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.9k works
- 2 China 1.7k works
- 3 United Kingdom 591 works
- 4 Italy 421 works
- 5 Japan 389 works
- 6 Canada 366 works
- 7 Spain 359 works
- 8 Germany 329 works
- 9 France 258 works
- 10 South Korea 222 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Inflammatory Bowel Disease research?
By volume in 2022–2025, Icahn School of Medicine at Mount Sinai publishes the most Inflammatory Bowel Disease research, followed by Cleveland Clinic and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 Icahn School of Medicine at Mount SinaiUnited States 78 works
- 2 Cleveland ClinicUnited States 58 works
- 3 University of North Carolina at Chapel HillUnited States 57 works
- 4 KU LeuvenBelgium 51 works
- 5 University of ChicagoUnited States 49 works
- 6 University of CalgaryCanada 43 works
- 7 Sun Yat-sen UniversityChina 43 works
- 8 Western UniversityCanada 34 works
- 9 Amsterdam University Medical CentersNetherlands 33 works
- 10 Tel Aviv UniversityIsrael 32 works
Who are the leading researchers in Inflammatory Bowel Disease?
The most-cited researchers publishing on Inflammatory Bowel Disease include Mark J. Daly, Dan J. Stein and Reza Malekzadeh.
- 1 Mark J. Daly United States 9.6k citations
- 2 Dan J. Stein South Africa 7.7k citations
- 3 Reza Malekzadeh Iran 6.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Inflammatory Bowel Disease research done?
The largest centres of Inflammatory Bowel Disease research in 2022–2025 are New York (United States), London (United Kingdom), Guangzhou (China) and Beijing (China).
Largest cities, 2022–2025
Where is the best place to study Inflammatory Bowel Disease?
Among universities, judged by research, Humanitas University, Icahn School of Medicine at Mount Sinai and Nanjing University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Humanitas UniversityItaly | 76.6 | 40.8% | 23.5× | 16 | +259.8% |
| 2 | Icahn School of Medicine at Mount SinaiUnited States | 70.8 | 25.8% | 17.9× | 78 | +84.9% |
| 3 | Nanjing University of Chinese MedicineChina | 68.9 | 29.0% | 14.0× | 31 | +592.9% |
| 4 | Chengdu University of Traditional Chinese MedicineChina | 68.3 | 49.2% | 10.3× | 21 | — |
| 5 | Vita-Salute San Raffaele UniversityItaly | 68.1 | 40.9% | 16.0× | 19 | — |
| 6 | Zhejiang Chinese Medical UniversityChina | 67.8 | 30.0% | 11.5× | 26 | +310.3% |
| 7 | Guangzhou University of Chinese MedicineChina | 62.6 | 36.4% | 9.5× | 16 | +133.0% |
| 8 | Medical University of LodzPoland | 60.8 | 36.8% | 9.4× | 13 | +118.0% |
| 9 | Western UniversityCanada | 60.0 | 26.5% | 7.0× | 34 | +122.8% |
| 10 | KU LeuvenBelgium | 58.2 | 20.1% | 6.3× | 50 | +96.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Inflammatory Bowel Disease research growing?
Output in 2018–2022 was 49% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Inflammatory Bowel Disease.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.